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ABSTRACT
Endoglin plays a crucial role in pathophysiological processes such as
hereditary hemorrhagic telangiectasia (HHT), preeclampsia and
cancer. Endoglin expression is upregulated during the monocyte-to-
macrophage transition, but little is known about its regulation and
function in these immune cells. Two different alternatively spliced
isoforms of endoglin have been reported, L-endoglin and S-endoglin.
Although L-endoglin is the predominant variant, here, we found that
there was an increased expression of the S-endoglin isoform during
senescence of the myeloid lineage in human and murine models. We
performed a stable isotope labelling of amino acids in cell culture
(SILAC) analysis of both L-endoglin and S-endoglin transfectants in
the human promonocytic cell line U937. Analysis of differentially
expressed protein clusters allowed the identification of cellular
activities affected during aging. S-endoglin expression led to
decreased cellular proliferation and a decreased survival response
to granulocyte-macrophage colony-stimulating factor (GM-CSF)-
induced apoptosis, as well as increased oxidative stress. Gene
expression and functional studies suggested that there was a non-
redundant role for each endoglin isoform in monocyte biology. In
addition, we found that S-endoglin impairs themonocytic differentiation
into the pro-inflammatory M1 phenotype and contributes to the
compromised status of macrophage functions during aging.
KEY WORDS: Cellular senescence, Macrophage, Endoglin,
Macrophage polarization, Aging, SILAC
INTRODUCTION
Endoglin (also known as CD105) is a type I homodimeric
transmembrane glycoprotein that can act as an auxiliary receptor
for members of the TGF-b superfamily (Cheifetz et al., 1992;
Bello´n et al., 1993). Structurally, endoglin belongs to the zona
pellucida (ZP) family of proteins that share a ZP domain of ,260
amino acid residues at their juxtamembrane extracellular region
(Llorca et al., 2007). Endoglin also contains, at its N-terminal
extracellular region, an orphan domain, comprising ,325 amino
acids whose sequence is not homologous to any other protein;
however, this domain has recently been identified as the minimal
active endoglin domain needed for partner recognition (Llorca
et al., 2007; Castonguay et al., 2011; Alt et al., 2012).
Endoglin expression and function has been widely described in
the context of endothelial cells and vascular physiology (Bernabeu
et al., 2007; Lo´pez-Novoa and Bernabeu, 2010), playing a key role
in many pathological processes, including hereditary hemorrhagic
telangiectasia (HHT), cancer angiogenesis, preeclampsia or
hypertension (Bernabeu et al., 2009; Shovlin, 2010; Kapur et al.,
2012; Rana et al., 2012; Valbuena-Diez et al., 2012). In addition,
increased levels of the membrane and soluble forms of endoglin
have been linked to inflammatory processes, such as wound
healing, atherosclerosis, psoriasis and rheumatoid arthritis (Rulo
et al., 1995; Conley et al., 2000; Torsney et al., 2002; Lo´pez-Novoa
and Bernabeu, 2010).
There are two different isoforms of endoglin that share an
identical extracellular domain but differ from each other in the
length and composition of their cytoplasmic tail (Cheifetz et al.,
1992; Bello´n et al., 1993). The endoglin gene (ENG) is
predominantly expressed as a long isoform (L-endoglin), but its
pre-mRNA can be alternatively spliced by a mechanism of intron
retention, yielding a less abundant form, known as short endoglin
(S-endoglin). This intron retention is driven by the SRSF1 splicing
factor, which physically competes with the minor spliceosome for
the elimination of the last intron between exons 13 and 14 (Blanco
and Bernabeu, 2011; Blanco and Bernabeu, 2012). When
transcribed, the last intron of ENG bears an early stop codon that
affects the open reading frame and truncates the mature protein at
the cytoplasmic region (Blanco et al., 2008). So far, most studies
published about endoglin have focused on L-endoglin. The
expression of the short variant (S-endoglin) was first described in
humans (Bello´n et al., 1993) and later in mice (Pe´rez-Go´mez et al.,
2005). Specific transcripts for L-endoglin and S-endoglin have been
detected in placenta, lung, heart, epidermis and liver, as well as in
epithelial, endothelial and monocytic cells (Bello´n et al., 1993;
Pe´rez-Go´mez et al., 2005). The cytoplasmic region of human L-
endoglin is composed of 47 amino acids with a high content of
serine and threonine residues that are susceptible to phosphorylation
(Lastres et al., 1994). In addition, the sequence Ser-Met-Ala (SMA)
in the C-terminal end of L-endoglin is a docking site for proteins
with a PDZ domain and is involved in cytoskeleton organization
(Koleva et al., 2006). By contrast, the sequence of the S-endoglin
cytoplasmic tail is only 14 amino acids long, the last seven residues
being specific for this isoform. These structural differences might
account for the distinct functional effects of L-endoglin and S-
endoglin (Blanco et al., 2008; Velasco et al., 2008).
Interestingly, a role for S-endoglin during endothelial
senescence has been described (Blanco et al., 2008). Thus, the
S-endoglin:L-endoglin ratio is increased during senescence of
human endothelial cells in vitro, as well as during aging of mice
in vascularized tissues. The switch between L-endoglin and S-
endoglin affects the TGF-b-mediated cell signalling, promoting
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the ALK5 (TGFBR1)–Smad3 pathway instead of the ALK1
(ACVRL1)–Smad1 route. This is due to the preferential affinity
of the short cytoplasmic domain for ALK5, which promotes the
expression of target genes such as SERPINE1 (PAI-1) and PTGS2
(cyclooxygenase-2, COX-2) and inhibits NOS3 (nitric oxide
synthase 3, eNOS). Furthermore, transgenic mice overexpressing
S-endoglin show hypertension, a decreased hypertensive response
to NO inhibition, a decreased vasodilatory response to TGF-b1
administration and decreased eNOS expression in lungs and
kidneys, supporting the involvement of S-endoglin in the NO-
dependent vascular homeostasis (Blanco et al., 2008). Taken
together, these results suggest that S-endoglin is induced during
endothelial senescence and that it might contribute to age-
dependent vascular pathology.
During aging, immune and inflammatory responses are impaired
in a general immunosenescence process where macrophage
functions are compromised (Cassado Ados et al., 2011; Mahbub
et al., 2012). Aged macrophages show reduced functional activity,
leading to accumulation of unphagocytosed cellular debris, chronic
inflammation and exacerbation of tissue damage and aging (Shaw
et al., 2010; Li, 2013). Two physically and functionally distinct
macrophage subsets have been described in the mouse peritoneal
cavity (Ghosn et al., 2010), which represent different senescence
stages. Thus, the long-term resident large peritoneal macrophages
(LPMs) exhibit morphological and functional characteristics
described in senescent cells, including large size, prominent
vacuolization, reduced phagocytic capacity and low expression of
MHC class II molecules. In steady-state conditions, .90% of
peritoneal macrophages are LPMs and the remaining ones are
small peritoneal macrophages (SPMs, young macrophages derived
from newly recruited blood monocytes). Upon inflammatory
stimuli, the loss of LPMs correlates with the cell renewal of the
peritoneal cavity, which is characterized by the enrichment of
SPMs. All these data suggest that the peritoneal cavity is a useful
tool to analyse macrophage immunosenescence in these two cell
subsets (Cassado Ados et al., 2011). Macrophages participate in the
immune response according to a preferential M1 or M2
polarization, which is involved not only in the response to
pathogens, tumour progression and angiogenesis, but also in tissue
homeostasis, autoimmunity and fibrosis (Sunderko¨tter et al., 1994;
Werner and Alzheimer, 2006; Benoit et al., 2008). Although many
studies on endoglin have focused on endothelial cells, endoglin
expression has also been detected in some myeloid precursors and
macrophages. Thus, endoglin acts as a crucial regulator of
hematopoietic development, in part by modulating the signalling
involving members of the TGF-b superfamily (Borges et al., 2012).
Later in development, endoglin is present at low levels on
monocytes, but it is markedly upregulated during the monocyte–
macrophage transition (Lastres et al., 1992; O’Connell et al.,
1992). Moreover, in the human monocytic line U937, ectopic
expression of endoglin counteracts TGF-b1-dependent cellular
responses (Lastres et al., 1996). Overall, the role of endoglin in the
myeloid lineage is poorly understood, especially regarding the
individual function of each isoform. Although endoglin expression
in human macrophages has been detected in several tissues (Lastres
et al., 1992; O’Connell et al., 1992), nothing is known about the
regulation and function of the individual endoglin isoforms in
macrophages or their contribution to disease. Here, we show that S-
endoglin is a marker of macrophage senescence, and both endoglin
isoforms contribute to the monocyte-to-macrophage transition
and polarization during immunosenescence, thus modulating the
system responses due to aging.
RESULTS
Transcript expression of endoglin isoforms in monocytes
and macrophages
Endoglin is expressed at low levels on monocytes, but it is
markedly upregulated during the monocyte–macrophage
transition (Lastres et al., 1992; O’Connell et al., 1992). Both L-
endoglin and S-endoglin isoforms have been detected in
monocytic cell lines treated with phorbol esters (Bellon et al.,
1993), but the regulation of these isoforms in primary cultures of
macrophages has not been studied. Because S-endoglin is a
marker of cellular senescence (Blanco et al., 2008), we assessed
the mRNA expression of both endoglin isoforms in monocytes
and macrophages with a senescence-like stage that were
subjected to oxidative stress. First, macrophages were obtained
from the peritoneal cavity of 2-month-old mice. Most of these
cells correspond to the myeloid lineage, mainly to tissue-resident
LPMs (Cassado Ados et al., 2011). As a biomarker of
macrophage senescence, we used b-galactosidase activity
(Cassado Ados et al., 2011). A large proportion of the LPMs
were positive for the senescence-associated b-galactosidase
staining (Fig. 1A) and there was a marked increase in the
percentage of senescent macrophages after hydrogen peroxide
(H2O2) treatment (Fig. 1B). In addition, increased levels of S-
endoglin were observed upon oxidative stress, as shown by semi-
quantitative RT-PCR analysis of endoglin transcripts (Fig. 1C).
In addition, oxidative-stress-induced senescence in activated
monocytes from four human different donors demonstrated a
clear increase in the transcript levels of the senescence markers S-
endoglin and PAI-1, whereas L-endoglin levels underwent a
much lower increase (Fig. 1D). Zymosan particles prepared
from yeast cell walls (Saccharomyces cerevisiae) and their
intraperitoneal injection in mice is commonly used to enrich the
peritoneal cavity in macrophages. To assess the effect of in vivo
aging, LPMs and recruited SPMs were analysed upon zymosan
treatment (Fig. 1E,F). S-endoglin levels were clearly increased in
both LPMs and SPMs in mice that were 6 and 12 months old (up
to 16-fold), relative to 2-month-old animals. Moreover, the
senescence marker PAI-1 showed a statistically significant
increase in LPMs (at 12 months), whereas L-endoglin transcript
levels were augmented in LPMs (at 6 and 12 months) and SPMs
(at 12 months), although at lower levels than S-endoglin. Of note,
the upregulation of S-endoglin preceded that of PAI-1 in LPMs
(Fig. 1E), and no significant changes of PAI-1 levels in
infiltrating SPMs during aging were observed (Fig. 1F).
Unfortunately, there are no appropriate antibodies able to
distinguish between L-endoglin and S-endoglin proteins for
these studies. Human S-endoglin and L-endoglin proteins vary
from each other in their cytoplasmic tails that contain 14 and 47
amino acids, respectively, with only a sequence of seven residues
being specific for S-endoglin (Lo´pez-Novoa and Bernabeu,
2010). Similar differences are also present in murine endoglin
isoforms. These small structural differences explain the lack of
appropriate tools to clearly distinguish between L-endoglin and
S-endoglin proteins. Taken together, these results suggest that S-
endoglin is a marker of macrophage senescence that is
upregulated during in vitro oxidative-stress-induced senescence
and in vivo aging.
Identification of differentially expressed proteins in
monocytic endoglin transfectants
To assess the impact of the two endoglin isoforms in the monocytic
proteome, stable transfectants of U937 cells overexpressing human
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L-endoglin or S-endoglin, as well as mock transfectants, were used
(Lastres et al., 1996). Although this experimental approach does
not necessarily reflect the in vivo situation, it represents a useful
tool to specifically dissect the individual contribution of endoglin.
Protein expression of both endoglin isoforms is markedly enhanced
in respect to the basal levels of mock transfectants, as shown by
immunofluorescence flow cytometry (Fig. 2A). The presence of L-
endoglin and S-endoglin transcripts could be detected by
qualitative RT-PCR analysis in all transfectants (Fig. 2B).
Proteomics analysis using stable isotope labelling of amino acids
in cell culture (SILAC) technology was applied to quantify
differences in protein expression level among transfected U937
cells. A schematic illustration of the experimental outline is shown
in supplementary material Fig. S1A–C. After metabolic labelling
with different isotopes, equal numbers of cells were mixed, and
subcellular fractions were subjected to SDS-PAGE followed by
trypsin digestion (supplementary material Fig. S1A). Samples were
processed as described in the Materials and Methods and we were
able to identify and quantify a set of 890 differentially expressed
proteins in the three subcellular fractions from endoglin
transfectants (supplementary material Table S1). A summary of
the top ten downregulated and upregulated proteins in both L-
endoglin and S-endoglin transfectants is shown in supplementary
material Table S2. Interestingly, many of these proteins (marked
with an asterisk) were deregulated in both types of transfectants.
The Venn diagram representation in Fig. 3 depicts the numbers of
upregulated and downregulated proteins compared to values in
mock transfectants. This representation shows that both endoglin
Fig. 1. Expression of endoglin isoforms in monocytes and macrophages upon oxidative-stress-induced senescence and during aging.
(A–C) Oxidative-stress-induced senescence in mouse peritoneal macrophages (Mø). Resident LPMs obtained from the peritoneal cavity of 2-month-old mice
were incubated in the absence or the presence of hydrogen peroxide (150 mM H2O2) for 1 h and stained for the senescence-associated b-galactosidase
activity (A). The positivity for this marker is significantly higher in H2O2-treated cells compared to controls (B). Cells cultured under oxidative stress conditions
present higher levels of S-endoglin than untreated cells, as shown by semi-quantitative RT-PCR; S, S-endoglin; L, L-endoglin (C). (D) Quantitative PCR of
oxidative stress-induced senescent human macrophages. Human monocytes were purified from PBMCs by magnetic cell sorting using anti-CD14 and were
cultured for 3 days. Adherent cells were incubated in the absence or the presence of 150 mM H2O2 and transcript levels were measured. Results are expressed
as fold-induction values with respect to untreated cells. Upon oxidative stress, activated monocytes show an increase in both S-endoglin and PAI-1 senescence
markers. (E,F) Effect of aging on large and small mouse peritoneal macrophages. Mouse LPMs and SPMs were isolated from untreated (E) and zymosan-
treated (F) animals, respectively. Cells were collected from 2-month-old (2m), 6-month-old (6m) and 12-month-old (12m) old mice. Total RNA was extracted
and subjected to quantitative RT-PCR to measure S-endoglin (S-Eng), L-endoglin (L-Eng) or PAI-1 transcript levels. Results were normalized to those in
2-month-old animals. Increased levels of S-endoglin in both LPM and newly recruited SPM (due to zymosan) were observed. The statistical significance of 6-
month and 12-month samples with respect to 2-month-old mice are indicated. *P,0.05; **P,0.01; ***P,0.001.
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isoforms produced the same effect in some of the regulated
proteins, suggesting that this regulation is mediated by their shared
extracellular domain (Fig. 3). In fact, the same regulatory effect
was observed for 166 proteins (26 upregulated and 140
downregulated). By contrast, six proteins showed an opposite
regulation between L-endoglin and S-endoglin transfectants
(upregulated in L-endoglin and downregulated in S-endoglin
cells). Of note, there were a large number of proteins (546) with a
different behaviour in either L-endoglin (106 upregulated and 143
downregulated) or S-endoglin (36 upregulated and 261
downregulated) transfectants, suggesting that this effect depends
on the endoglin cytoplasmic region.
Validation studies and functional pathways analysis of the
proteome list
To confirm the results from the SILAC analysis, we decided to
validate some of the differentially expressed proteins. Nine
representative proteins were selected for this purpose: Smad3, a
transcription factor that mediates TGF-b signalling and whose
activity is modulated by endoglin (Bernabeu et al., 2007);
calmodulin, a Ca2+-binding messenger protein that regulates
inflammation, cell cycle, apoptosis and immune responses
(Racioppi and Means, 2012); and CD13, a myeloid-specific cell
surface alanyl aminopeptidase (Ansorge et al., 2009). In addition,
superoxide dismutase 2 (SOD2), peroxiredoxin-1 (PRDX1),
proline-serine-threonine phosphatase-interacting protein 1
(PSTPIP1), cyclin-dependent kinase 8 (CDK8), integrin a1 and
cathepsin G were also selected. Among these, cathepsin G,
PSTPIP1 and SOD2 are within the top three, top ten and top 16
dysregulated proteins, respectively (supplementary material
Tables S1, S2). Analysis of the differentially expressed protein
list showed that each of these proteins underwent a distinct
regulation (supplementary material Table S1; Fig. 4A).
Validation studies confirmed a similar behaviour by western
blot and flow cytometry experiments (Fig. 4B). Thus, decreased
protein levels of Smad3 and integrin a1 were detected in both
endoglin transfectants, calmodulin and peroxiredoxin 1 protein
levels did not change in L-endoglin transfectants, but were
repressed in S-endoglin cells, and the protein expression of CD13,
cathepsin G and PSTPIP1 was markedly increased in both
endoglin transfectants compared with the mock condition.
Next, we investigated the possible biological functions affected
by endoglin overexpression. The SILAC protein list was subjected
to the bio-informatic Ingenuity pathways analysis (IPA) using the
Ingenuity knowledge base (genes only) as a reference set. The top
25 significantly altered biofunctions are shown for L-endoglin and
S-endoglin U937 transfectants with respect to mock controls in
supplementary material Fig. S2. Among the cellular processes
affected in both types of endoglin transfectants are cellular growth
and proliferation, immune cell trafficking, cell death and survival,
as well as homeostasis of free radicals, all of which are
compromised during aging. To assess whether these cellular
functions were indeed affected in endoglin transfectants, specific
functional assays were carried out. Both endoglin transfectants
show an altered ‘cell trafficking’ profile in the bioinformatics
analysis, most likely due to the marked reduction of integrin levels,
including those of the a1, a5, b1 and b2 subunits (Fig. 5A;
supplementary material Table S1). Integrins are involved in cell
adhesion, a process impaired during cellular senescence. Among
the modulated integrins, integrin a5 is the one that showed the
highest reduction (log2 ratios: L-endoglin, 20.827; S-endoglin,
20.881). Thus, we postulated that the decreased SILAC expression
ratio of integrin a5 would lead to weaker cell adhesion to
fibronectin. Indeed, cell adhesion assays clearly demonstrated an
impaired binding of both endoglin transfectants to fibronectin
compared to mock controls (Fig. 5B). Furthermore, the decreased
cell adhesion could be observed at different adhesion time points
(5–60 min). These data suggest that protein expression of both
endoglin isoforms in monocytic cells reduces their adhesion to the
extracellular matrix.
When cells enter senescence they undergo an arrest during the
cell cycle and lose their capacity to proliferate. The IPA results
Fig. 2. Endoglin expression analysis in U937 transfectants. Stable U937
cell transfectants ectopically expressing L-endoglin (L-Eng), S-endoglin
(S-Eng) as well as mock transfectants (Mock) were analysed by
immunofluorescence flow cytometry with anti-endoglin antibodies (A); the
percentage of positive cells is indicated by the horizontal bar. Semi-
quantitative RT-PCR analysis shows the presence of L-endoglin and S-
endoglin transcripts in transfectants (B).
Fig. 3. Venn diagram representation of the protein identification
summary of all subcellular fractions from L-endoglin and S-endoglin
transfectants. Upregulated and downregulated protein levels are
compared to values in mock transfectants. The same regulatory effect in both
isoforms is observed for 166 proteins (26 upregulated and 140
downregulated). Six of the proteins show an opposite regulation between L-
endoglin and S-endoglin transfectants (upregulated in L-endoglin and
downregulated in S-endoglin cells). A large number of proteins (546) showed
an regulation either by only L-endoglin (106 upregulated and 143
downregulated) or by only S-endoglin (36 upregulated and 261
downregulated) transfectants.
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also yielded ‘cell cycle’ as one of the compromised biological
functions, although the statistical significance was much higher in
S-endoglin (lowest P-value, 4.76 1026) than L-endoglin (lowest
P-value, 3.9961024) transfectants. This is in agreement with the
decreased protein expression in S-endoglin, but not in L-endoglin,
transfectants of cyclin-dependent kinases CDK1, CDK7 or
CDK8, as well as in the cell cycle regulators cell division cycle
20 homolog (CDC20) and calmodulin (Fig. 5C; Fig. 4B). Indeed,
the growth rate was significantly slower in S-endoglin
transfectants compared to mock controls or L-endoglin
transfectants (Fig. 5D). This retarded proliferation could be
detected after 24 h of culture and was more evident 48 h after
culture synchronization.
According to the IPA analysis, cell death and survival is
affected in both the endoglin transfectants, although in opposite
ways regarding apoptosis. Thus, pro-apoptotic proteins such as
Fig. 4. Validation of SILAC analysis at individual protein level. (A) SILAC ratio obtained from the proteomic analysis of superoxide dismutase 2 (SOD2),
peroxiredoxin 1, proline-serine-threonine phosphatase-interacting protein 1 (PSTPIP1), Smad3, cathepsin G (Cath-G), CDK8, calmodulin (CaM),
aminopeptidase N (CD13) and integrin a1. The data has been adapted from supplementary material Table S1 and ratios are represented in a linear scale.
Ratios within the 1.5–0.8 range are not included. (B) Western blot and immunofluorescence flow cytometry (bottom row) analyses of mock, S-endoglin (S-Eng)
and L-endoglin (L-Eng) U937 transfectants using specific antibodies. Protein levels were quantified by densitometry of the specific bands relative to b-actin (bA)
in western blot analyses and by measuring the expression index in flow cytometry analyses. Values are represented in the histograms where an arbitrary
value of 1 is given to mock transfectants. The statistical significance with respect to mock cells is indicated. *P,0.05; **P,0.01; ***P,0.001.
RESEARCH ARTICLE Journal of Cell Science (2014) 127, 2723–2735 doi:10.1242/jcs.143644
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BH3-interacting domain death agonist (BID), DNA fragmentation
factor subunit a (DFFA) or mammalian STE20-like protein
kinase 4 (MST4) have lower expression in L-endoglin, but not in
S-endoglin, transfectants, whereas pro-survival and apoptosis-
protective proteins like gelsolin (GSN) or mitochondrial antiviral
signalling (MAVS) have a higher expression in L-endoglin, but not
S-endoglin, transfectants compared to mock controls (Fig. 5E). By
contrast, in S-endoglin, but not in L-endoglin, transfectants, levels
of pro-survival and anti-apoptosis proteins peroxiredoxin-1
(PRDX1), thioredoxin (TXN), ubiquitin-conjugating enzyme E2
Fig. 5. Functional validation of the pathway analysis. (A,B) Integrin levels and cell adhesion. (A) SILAC ratio obtained from the proteomic analysis of b1
(ITGA1), a5 (ITGA5) and b2 (ITGB2) integrins (supplementary material Table S1) in a logarithmic scale. In both endoglin transfectants, these three integrin
members showed a reduction in their expression levels, with a5 displaying the highest reduction (ITGA5; L-endoglin, 20.827 and S-endoglin, 20.881). (B) Cell
adhesion to fibronectin. Plates were coated with fibronectin or BSA, as indicated. L-endoglin, S-endoglin and mock U937 transfectants were labelled with CFSE,
loaded in the wells and incubated for different times. Each assay was performed in triplicate. The statistical significance of endoglin transfectants versus
mock cells is indicated. *P,0.05. (C,D) Cell-cycle-related proteins and cellular proliferation. (C) SILAC ratio obtained from the proteomic analysis of
cell-cycle-related proteins CDK8, CDK7, cell division cycle 20 homolog (CDC20) and CDK1 (supplementary material Table S1). (D) The proliferation rate of S-
endoglin-overexpressing U937 cells is decreased compared to mock or L-endoglin transfectants. The differences are statistically significant at 24 h (255.67 in
mock and 249.00 in L-endoglin versus 182.33 in S-endoglin; *P,0.05) and at 48 h (551.67 in mock and 566.00 in L-endoglin versus 392.33 in S-endoglin;
***P,0.001). (E,F) Cell survival, apoptosis and proteins involved. (E) SILAC ratio (log2) obtained from the proteomic analysis of BH3-interacting domain death
agonist (BID), DNA fragmentation factor subunit a (DFFA), mammalian STE20-like protein kinase 4 (MST4), gelsolin (GSN), mitochondrial antiviral signalling
(MAVS), peroxiredoxin-1 (PRDX1), thioredoxin (TXN), ubiquitin-conjugating enzyme E2 variant 1 (UBE2V1) and unconventional prefoldin RPB5 interactor 1
(URI1), which are involved in cell survival and apoptosis (supplementary material Table S1). (F) U937 cells were treated with increasing concentrations of GM-
CSF for 4 days and cell survival was determined using an MTT assay. (G,H) Reactive oxygen species and proteins involved. (G) SILAC ratio obtained from the
proteomic analysis of apoptosis-inducing factor mitochondrion-associated 1 (AIFM1), peroxiredoxin-6 (PRDX6), cytochrome b-245 b (CYBB) and
superoxide dismutase 2 (SOD2), which are involved in the homeostasis of free radicals (supplementary material Table S1). (H) U937 cells were incubated with
the ROS indicator H2DCFDA for 30 min in the dark at room temperature, lysed and their fluorescence was measured in a Varioskan Flash reader. Results are
relative to mock transfectants (arbitrary value).
RESEARCH ARTICLE Journal of Cell Science (2014) 127, 2723–2735 doi:10.1242/jcs.143644
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variant 1 (UBE2V1) and unconventional prefoldin RPB5 interactor
1 (URI1) are reduced compared to mock controls. These data
suggest that S-endoglin transfectants might exhibit a decreased
survival in response to pro-apoptotic stimuli. To test this
hypothesis, the granulocyte-macrophage colony-stimulating
factor (GM-CSF)-induced pro-apoptotic effect in U937 cells
(Okuma et al., 2000) was assessed. As shown in Fig. 5F, S-
endoglin transfectants showed a decreased survival rate in response
to three different doses of the pro-apoptotic cytokine, whereas L-
endoglin transfectants showed a slightly higher, but not significant,
survival rate than control cells.
The SILAC analysis also suggested that the metabolism of
reactive oxygen species (ROS) was affected in both endoglin
transfectants, as illustrated in Fig. 5G. Thus, the redox-
homeostasis-maintaining protein apoptosis-inducing factor
mitochondrion-associated 1 (AIFM1) and the antioxidant
protein peroxiredoxin-6 (PRDX6) were downregulated, whereas
the NADPH oxidase cytochrome b-245 b polypeptide (CYBB)
was upregulated in endoglin transfectants. Based on these data, it
can be postulated that L-endoglin and S-endoglin transfectants
might display an enhanced production of ROS levels. However,
this production might be compensated for in L-endoglin, but not
in S-endoglin transfectants owing to increased protein levels of
superoxide dismutase 2 (SOD2), which might contribute to free
radical scavenging (Fig. 5G). This interpretation is compatible
with the actual measurement of ROS production in U937 cells,
showing that S-endoglin expressing cells display levels of ROS
higher than those of L-endoglin or mock transfectants (Fig. 5H).
Overall, the selected proteins analysed in Fig. 5 represent a
large number of proteins involved in immune cell trafficking,
cellular growth and proliferation, and cell death and survival, as
well as homeostasis of free radicals (supplementary material Fig.
S2; Table S1). Given the high number of deregulated proteins
involved in each of these biological processes, it is unclear what
the specific contribution of each protein is. Rescue experiments of
the biological functions might be useful to dissect the
contribution of each protein. Taken together, these data suggest
that protein expression of both endoglin isoforms affect the
mentioned cellular processes associated with aging, whereas S-
endoglin appears to contribute to cellular senescence.
Endoglin isoforms in macrophage polarization
It is well known that aging impairs macrophage polarization into
M1 and M2 subtypes (Mahbub et al., 2012). Because S-endoglin
is upregulated upon macrophage senescence in vitro and during in
vivo aging (Fig. 1), we assessed the role of both endoglin
isoforms in the phorbol myristate acetate (PMA)-induced
macrophage differentiation of U937 cells (Caban˜as et al.,
1990). Thus, PMA-treated L-endoglin, S-endoglin and mock
U937 transfectants were analysed by quantitative PCR to assess
the transcript levels of different M1 and M2 marker genes
(Fig. 6A). The expression of classical M1 interleukin genes, like
IL6, IL23A or IL12A, was higher in mock and L-endoglin
transfectants than in S-endoglin-transfected cells. By contrast,
typical M2 genes, like musculoaponeurotic fibrosarcoma
oncogene homolog B (MAFB), stabilin 1 (STAB1) or serpin
peptidase inhibitor, clade B (SERPINB2) were more highly
expressed in S-endoglin transfectants than in mock cells or L-
endoglin transfectants (Fig. 6A). Therefore, and at the
transcriptomic level, the presence of S-endoglin skews myeloid
cell polarization towards M2, whereas the expression of L-
endoglin does not have an overt influence of the gene expression
of polarization markers, further emphasizing the different
signalling capabilities of both endoglin isoforms.
Next, we assessed the potential influence of both endoglin
isoforms on the functional polarization of myeloid cells using the
PMA-induced differentiation of U937 cells. To that end, the
responsiveness of endoglin transfectants to lipopolysaccharide
(LPS), which favours the acquisition of an M1 phenotype, was
evaluated (Fig. 6B). Analysis of the secreted cytokine profile
showed the release of pro-inflammatory cytokines to the
supernatant in mock, L-endoglin and S-endoglin populations
(Fig. 6B). Overall, endoglin transfectants displayed lower levels
of LPS-induced pro-inflammatory cytokines than mock controls
(Fig. 6B). S-endoglin transfectants showed the lowest
inflammatory response among the three cell types, in agreement
with their M2-like phenotype observed in Fig. 6A. Moreover, L-
endoglin cells displayed an inflammatory profile stronger than
that of S-endoglin transfectants, a finding compatible with their
gene expression pattern (Fig. 6A, upper panel). This M1-like
phenotype associated with L-endoglin is especially evident in the
case of the cytokines C5/C5a, I-309, IL8, IP10 and Rantes.
Next, we investigated the underlying molecular basis for the
role of endoglin in macrophage polarization. It is noteworthy that
activin-A is a key regulator of macrophage polarization that
promotes a proinflammatory phenotype and inhibits the
acquisition of an anti-inflammatory status (Sierra-Filardi et al.,
2011). Because gene expression experiments showed an altered
regulation of activin-A (INHBA) transcription in endoglin
transfectants (Fig. 6A), we assessed the possible deregulated
protein expression of this cytokine in U937 transfectants. Of
note, and for technical reasons, our SILAC protein analysis
did not include the secreted proteome fraction of the transfectants
and therefore, no data about activin-A protein expression
was available. As shown in Fig. 6D, secretion of activin-A
was markedly increased (more than twofold) in L-endoglin
transfectants compared to mock controls. By contrast, activin-A
levels in culture supernatants of S-endoglin transfectants were
clearly reduced relative to controls. Taken together, the
polarization studies suggest that, in monocytic cells, L-endoglin
promotes an M1-like phenotype, whereas S-endoglin favours the
expression of M2 markers and functions.
DISCUSSION
The effect of aging on the innate immune system has a
detrimental effect on the health of elderly individuals. Indeed,
there is a substantial decline in the ability to resist infectious
diseases and in the generation of robust protective immune
responses among the elderly (Bender, 2003; Dace and Apte,
2008). Macrophages are crucial components of the innate
immune system, but their senescence protein markers and
related functions during aging have been poorly investigated.
Here, we have analysed, for the first time, the regulated
expression and function of two endoglin isoforms during
macrophage senescence. We find that S-endoglin is a marker of
macrophage senescence, being upregulated during in vitro
senescence induced by oxidative stress and in vivo aging. This
upregulation preceded that of PAI-1, a well-known senescence
marker, suggesting that S-endoglin is an early marker of
macrophage senescence. Previous studies have also shown that
S-endoglin is a contributor to age-dependent cardiovascular
pathology (Blanco et al., 2008). The upregulation of S-endoglin
unbalances the ratio of S-endoglin to L-endoglin isoforms, in turn
affecting the TGF-b signalling pathways of endothelial cells.
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Both endoglin isoforms interact with the TGF-b signalling
receptors types I (ALK1 and ALK5) and II (TbRII) and
modulate cellular responses to TGF-b (Lastres et al., 1996;
Guerrero-Esteo et al., 2002; Blanco et al., 2008; Velasco et al.,
2008). More specifically, S-endoglin promotes the TGF-b–
ALK5-dependent route, whereas L-endoglin activates the TGF-
b–ALK1-dependent pathway. Interestingly, PAI-1 is a target gene
of the S-endoglin–ALK5 pathway, suggesting that S-endoglin is
upstream of PAI-1. This is in agreement with the upregulation of
S-endoglin and PAI-1 in LPMs, but not in SPMs, and with the
finding that the S-endoglin increase precedes that of PAI-1 in
senescent macrophages.
To date, most of the studies on endoglin have been focused on
the predominant L-endoglin isoform, although substantial levels
of S-endoglin mRNA are coexpressed with L-endoglin in vivo
(Bello´n et al., 1993; Pe´rez-Go´mez et al., 2005; Blanco et al.,
Fig. 6. Polarization of endoglin U937 transfectants. (A) Analysis of the M1 and M2 gene profile upon macrophage differentiation. Mock, L-endoglin and S-
endoglin U937 transfectants were treated with PMA for 3 days and specific M1 (IL6, INHBA, IL23A, IL2A and IL1A) and M2 (MAFB, STAB1, SERPINB2, FOLR2
and CD163) marker genes were analysed by quantitative RT-PCR. Results were normalized to the values for mock transfectants. L-endoglin and S-endoglin
transfectants show an M1-like and M2-like phenotype, respectively. (B) U937 transfectants were treated with PMA, and LPS was added for the last 12 h of
incubation. Inflammatory cytokines in the culture medium were analysed with a kit of capture antibodies spotted on nitrocellulose membranes. Expression
of both endoglin isoforms impairs the typical inflammatory response compared to mock cells, although the overall inhibitory effect of S-endoglin was
stronger than that of L-endoglin. Cytokine levels in the absence of stimuli were negligible. (C) Levels of activin-A in culture supernatants from mock, L-endoglin
and S-endoglin transfectants were determined by ELISA. L-endoglin transfectants induce, whereas S-endoglin transfectants inhibit, the expression of activin-A.
The statistical significance of endoglin transfectants versus mock cells (*P,0.05; **P,0.01; ***P,0.001) and of S-endoglin transfectants versus L-endoglin
transfectants (#P,0.05; ##P,0.01; ###P,0.001) is indicated.
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2008). Unfortunately, little is known about the role of endoglin
isoforms in the myeloid lineage. To assess the impact of the two
endoglin isoforms in monocytic cells, stable transfectants of
U937 cells overexpressing human L-endoglin or S-endoglin were
subjected to a proteomic analysis using the SILAC technology.
The biological functions affected by endoglin overexpression
were studied using IPA. This showed that, among the altered
biofunctions, there were cellular processes affected in both
types of endoglin transfectants, including cellular growth and
proliferation, immune cell trafficking, and cell death and survival,
as well as homeostasis of free radicals, all of which are
compromised during aging. A common feature of L-endoglin
and S-endoglin transfectants is their general decrease of integrin
levels (at least a1, a5, b1 and b2 integrin subunits), in agreement
with their decreased fibronectin-dependent cell adhesion. These
data not only show that expression of both endoglin isoforms in
monocytic cells reduces their adhesion to the extracellular matrix,
but that it also impairs their trafficking, which necessarily
involves cell adhesion. Supporting this interpretation, studies in
different cell types have shown that overexpression of either L-
endoglin or S-endoglin leads to reduced cellular migration
(Guerrero-Esteo et al., 1999; Liu et al., 2002; Conley et al.,
2004; Bernabeu et al., 2007). Furthermore, the upregulation of S-
endoglin during macrophage senescence is in line with the
decreased migration of myeloid cells, as well as the impaired
anti-inflammatory response, observed during aging (Shaw et al.,
2010; Li, 2013). Endoglin expression is finely regulated during
hematopoietic development and differentiation. For example,
hematopoietic stem cells express endoglin prior to a
downregulation during cell development and mobilization
(Chen et al., 2003). In addition, endoglin is markedly
upregulated during monocyte activation to macrophages
(Lastres et al., 1992). Thus, it can be postulated that the
increased expression of endoglin is associated with resident
niches of hematopoietic stem cells or tissue macrophages.
Accordingly, the resident large macrophages of the peritoneal
cavity are mostly senescent (Cassado Ados et al., 2011) and show
increased endoglin expression during aging (Fig. 1E).
The shared behaviour of L-endoglin and S-endoglin U937
transfectants regarding integrin expression and cell adhesion can
probably be explained by the fact that the extracellular domain of
endoglin is the same in both isoforms. By contrast, other cellular
functions were differentially affected by L-endoglin or S-
endoglin expression, suggesting that these functions are
dependent on the distinct cytoplasmic tail of each endoglin
isoform. Thus, and at variance with L-endoglin, S-endoglin
expression led to decreased cellular proliferation and a decreased
survival response to GM-CSF-induced apoptosis, as well as to
increased oxidative stress (Fig. 5). This phenotype of S-endoglin-
expressing cells fits well with that of cellular senescence,
suggesting that S-endoglin is not only a marker of macrophage
senescence but also contributes to the compromised status of
macrophage functions during aging (Allen, 1998; Colantoni et al.,
2001; Lloberas and Celada, 2002; Plowden et al., 2004).
We also describe for the first time that endoglin expression
alters the differentiation and polarization processes of
macrophages (Fig. 6). Polarization of macrophages is crucial in
the immune response to pathogens, and in tumour progression,
autoimmunity and fibrosis (Werner and Alzheimer, 2006; Benoit
et al., 2008); this polarization activity is impaired during aging,
leading to a deficient macrophage function and activation
(Gomez et al., 2005; Pello et al., 2011). Macrophages can be
subdivided into classical pro-inflammatory M1 macrophages, or
alternative anti-inflammatory M2 macrophages (Mantovani et al.,
2004). Importantly, these macrophage subpopulations are capable
of switching phenotypes based on the stimuli (Arnold et al.,
2007). Our polarization studies suggest that in monocytic U937
cells, L-endoglin promotes an M1-like phenotype, whereas S-
endoglin favours the expression of M2 markers (Fig. 6).
Classically activated M1 macrophages secrete pro-inflammatory
cytokines, such as tumor necrosis factor (TNF-a), interleukin-12
(IL-12) and the TGF-b family member activin-A, and exert anti-
tumoricidal activity. By contrast, activated M2 macrophages
secrete anti-inflammatory cytokines, such as IL-4, IL-10 and
TGF-b1, which promote age-associated processes, such as
fibrosis, atherosclerosis and tumour growth (Mantovani et al.,
2004; Pello et al., 2011). These findings suggest that S-endoglin
might contribute to the abnormal inflammatory response
associated with aging by inducing an M2-like phenotype in
macrophages.
The opposing behaviour of L-endoglin versus S-endoglin
regarding the M1–M2 polarization is clearly illustrated by the
basal secretion of activin-A in U937 transfectants (Fig. 6D).
Activin-A expression is upregulated on activation and in response
to inflammatory mediators (Jones et al., 2007; Robson et al.,
2008; Phillips et al., 2009), but is suppressed by anti-
inflammatory glucocorticoids (Yu et al., 1996; Scutera et al.,
2008). We find that production of activin-A is markedly increased
by L-endoglin and clearly reduced by S-endoglin, in agreement
with the M1-like and M2-like phenotypes, respectively. Of note,
activin-A is a key modulator of the polarization (Sozzani and
Musso, 2011), whose activity depends on the species and
environmental context. Recently, it has been described that
activin-A contributes to M1 macrophage polarization and
prevents the expression of M2-specific markers in humans
(Sierra-Filardi et al., 2011) Interestingly, a steep increase in
activin-A levels during aging, especially in the last decades of life
has been described in healthy adult men and post-menopausal
women (Baccarelli et al., 2001). Because activin-A is a ligand of
endoglin (Barbara et al., 1999), the functional interplay between
the S-endoglin and activin-A in senescent macrophages deserves
to be further investigated.
MATERIALS AND METHODS
Cell culture and SILAC
Stable transfectants of endoglin isoforms (L and S) and mock condition
(M) in the U937 cell line were cultured as described previously (Lastres
et al., 1996). For the SILAC assays, cells were cultured in specific
SILAC-ready RPMI 1640 (Thermo Scientific) supplemented with 10%
dialysed fetal bovine serum, 100 U/ml streptomycin/penicillin at 37 C˚
under a humidified atmosphere with 5% CO2. Metabolic labelling of
transfectants with non-radioactive isotopes was carried out as follows: (1)
Light-isotope labelling, L-Lys + L-Arg; (2) medium-isotope labelling,
[13C6]L-Lys + [
13C6]L-Arg; and (3) heavy-isotope labelling,
[13C6],[
15N2]L-Lys + [
13C6],[
15N4]L-Arg (Thermo Scientific). Cell
viability was checked by Trypan Blue staining and proliferation was
measured in a Neubauer chamber. At a population doubling level of six (a
label up to 95% is assumed), equal numbers of cells were mixed in the
direct combination (MockLight+L-EngHeavy+S-EngMedium) and swapping
(MockMedium+L-EngLight+S-EngHeavy). Then, protein enrichment was
made after subcellular fractioning into membrane, cytoplasmic and
nuclear compartments, using the subcellular protein fractionation kit for
cells in culture (Thermo Scientific). Fractions were individually loaded
and separated in non-reducing and queratin-free SDS-PAGE. After
staining with colloidal Coomassie (Invitrogen), the entire gel lane was cut
into 10–14 pieces of equal size and subjected to in-gel tryptic digestion
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essentially as described previously (Wilm et al., 1996). Briefly, the gel
pieces were destained and washed and, after dithiothreitol reduction and
iodoacetamide alkylation, proteins were digested with porcine trypsin
(sequencing grade modified; Promega, Madison, WI) overnight at 37 C˚.
The resulting tryptic peptides were extracted from the gel pieces with
30% acetonitrile and 0.3% trifluoroacetic acid, and the mixture was
evaporated in a vacuum centrifuge to remove the organic solvents. For
validation studies, U937 cell transfectants were grown in standard RPMI
medium supplemented with 10% heat-inactivated fetal calf serum (FCS),
2 mM L-glutamine, and 100 U/ml penicillin/streptomycin.
Protein mass spectrometry analysis
Briefly, peptides were loaded onto a C18-A1 ASY-Column 2-cm
precolumn (Thermo Scientific) and then eluted onto a Biosphere C18
column (NanoSeparations) and separated using a 180-min gradient
[170 min with 2–35% acetonitrile (ACN) gradient using buffer A, 0.1%
formic acid, 2% ACN; and buffer B, 0.1% formic acid, 99.9% ACN] at a
flow-rate of 250 nl/min on a nanoEasy HPLC (Proxeon) coupled to a
nanoelectrospray ion source (Proxeon). Mass spectra were acquired on
the LTQ-Orbitrap Velos (Thermo Scientific) in the positive ion mode.
Singly charged ions and unassigned charge states were rejected. After
mass spectrometry analysis, raw files were searched against the human
SwissProt database (SwissProt_57.15.fasta) using the MASCOT search
engine (version 2.3, Matrix Science) through Proteome Discoverer
(version 1.3.0.339) (Thermo). Identified peptides were validated using
Percolator algorithm (Ka¨ll et al., 2007) with a q-value threshold of 0.01,
and their relative quantification was performed using Proteome
Discoverer software. Light, medium and heavy spectra of the peptides
were analysed to get the protein level ratios based on the detected relative
abundance (supplementary material Fig. S1B). The final list of
differentially expressed proteins was obtained by correcting the ratio
deviation among samples. Thus, a truncated mean (or trimmed mean)
was applied to initially obtained ratios (supplementary material Fig.
S1C). In addition, individual peptide analysis using the Proteome
Discoverer software was carried out to correct for the weak, but
significant, arginine to proline metabolic switch (data not shown). For
each SILAC triplet (light, medium and heavy), Proteome Discoverer
determines the area of the extracted ion chromatogram and computes the
ratios of different combinations – heavy:light and medium:light (direct)
and light:medium and heavy:medium (swapping). Protein ratios are then
calculated as the median of all the quantified unique peptides belonging
to a certain protein. The final list was manually filtered excluding
proteins between 1.5 and 0.8 ratio and/or with different values or poor
peptide resolution in direct or swapping experiments. Values are
presented and analysed as the log2 of the obtained average ratio of
direct:swapping (L-Eng:Mock and S-Eng:Mock). The logarithmic ratio
distribution of the SILAC raw data after normalization respect to mock
transfectants is shown in supplementary material Fig. S3. As expected,
most of the identified proteins for both transfectants (.4000) have a
value around zero (no change compared to Mock). The definitive protein
list with the average of ratios was analysed using IPA software (Ingenuity
Systems). The protein list was clustered on a Venn diagram in order to
identify proteins that were either significantly up or down expressed in
both L-endoglin and S-endoglin transfectants compared to controls. The
image was obtained by an online tool developed in the Centro Nacional
de Biotecnologı´a (CNB, CSIC, Madrid) (Oliveros et al., 2000).
Immunodetection assays
For western blot analysis, transfectant cells were lysed in lysis buffer
(10 mM Tris-HCl pH 8, 150 mM NaCl, 1% NP-40, and a cocktail of
protease and phosphatase inhibitors) at 4 C˚. Lysate aliquots containing
40 mg protein were separated by SDS-PAGE under non-reducing
conditions. After separation, samples were electrotransferred onto a
PVDF membrane using the iBlotH System (Invitrogen). Immunodetection
was carried out by probing the membrane with rabbit polyclonal
antibodies against Smad3 (sc-6202), calmodulin (sc-5537), cathepsin-G
(sc-6512), CDK8 (sc-1521), PRX1 (sc-7381), PSTPIP1 (sc-390727) (all
Santa Cruz Biotechnology) or superoxide dismutase (S5069, Sigma)
overnight at 4 C˚, using a mouse monoclonal anti-b-actin antibody (AC-
15, Sigma) as a loading control, followed by incubation with the
corresponding horseradish-peroxidase-conjugated secondary antibody.
Protein bands were revealed using the SuperSignal chemiluminescent
substrate (Pierce, Rockford, IL, USA) and quantified using the Molecular
ImagerH Gel DocTM XR+ System with Image LabTM Software. For
immunofluorescence flow cytometry, cells were collected, centrifuged
and washed twice with 4 C˚ PBS. After blocking with 2% human AB+
serum in PBS for 30 min, cells were incubated with the mouse
monoclonal anti-endoglin (P4A4; Developmental Studies Hybridoma
Bank, University of Iowa), anti-CD13 (sc-53970, Santa Cruz
Biotechnology) or anti-a1 integrin (TS2/7; Francisco Sanchez-Madrid,
Hospital de La Princesa, Madrid, Spain) antibodies, followed by
incubation with Alexa-Fluor-488-conjugated goat anti-mouse-Ig
antibody (Invitrogen). Samples were analysed in an EPICS Coulter XL
flow cytometer. Results are expressed as an expression index, calculated
as the percentage of positive cells multiplied by their mean fluorescence
intensity. For activin-A measurements, culture supernatants from U937
cells were collected and centrifuged at 3000 g for 10 min to pellet
cellular debris. The levels of activin-A in the supernatants were
determined using the human Activin-A Quantikine ELISA kit
(ARY005; R&D Systems), following the manufacturer’s instructions.
Proliferation, survival and apoptosis assays
For proliferation assays, U937 cells were cultured at 1.26105 cells/ml in
RPMI 1640 medium supplemented with 10% FCS and growth was
observed at 24, 48 and 72 h. Proliferation measurements were carried out
by cell counting after Trypan Blue staining in a Neubauer chamber or in a
TC10 automated cell counter (BioRad). Each measurement was performed
in triplicate. For survival assays, U937 cells were seeded at 46104–86104
cells/ml in a 96-well plate and induction of apoptosis was carried out by
culturing the cells in the presence or absence of GM-CSF cytokine (10, 50
and 100 ng/ml) for up 4 days. Cultured cells were harvested and incubated
with MTT (0.25 mg/ml; Sigma) at 37 C˚ under 5% CO2 for 2 h. Then, the
plate was centrifuged at 100 g for 10 min and, after discarding the
medium, precipitated formazan crystals, generated by a differential activity
of succinate dehydrogenase, were resuspended in DMSO. The absorbance
was measured at 595 nm, followed by a background subtraction at 630 nm,
in an IEMS Reader (Thermo Scientific).
Measurement of ROS
For detection of ROS, U937 cells were incubated in 10 mM 29,79-
dichlorodihydrofluorescein diacetate (H2DCFDA) (Invitrogen, Paisley,
UK) for 30 min at room temperature in the dark. Samples were washed
twice and finally resuspended in NaOH 0.25 M to determine the
intracellular ROS levels. Fluorescence in lysates was measured in a
Varioskan Flash spectral scanning multimode reader (Thermo Scientific).
The relative fluorescence was normalized to the total protein content in
each condition. The protein concentration was determined by the
bicinchoninic acid assay (BCA protein assay kit, Pierce, Rockford, IL,
USA) using BSA as standard and following the manufacturer’s
instructions.
Cell adhesion assay to fibronectin
For cellular adhesion to fibronectin-coated surfaces, 24-well plates were
coated with 1 mg/cm2 of human fibronectin in 500 ml (Sigma) at 37 C˚ for
1 h. A total of 500,000 cells were washed twice in PBS, labelled with the
fluorescence probe carboxyfluorescein diacetate, succinimidyl ester
(CFSE, Invitrogen) and assayed. After the indicated time, cells
attached to the wells were washed and then lysed (25 mM Tris-
phosphate pH 7.8, 2 mM DTT, 2 mM CDTA, 10% glycerol, 1% Triton
X-100). Fluorescence in lysates was measured in a Varioskan Flash
spectral scanning multimode reader (Thermo Scientific).
Oxidative-stress-induced senescence in human and
mouse macrophages
Buffy coats were obtained from the Centro de Transfusion de la
Comunidad de Madrid, after informed consent and according to
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institutional guidelines. Human monocytes from four different donors
were purified from peripheral blood mononuclear cells (PBMCs) by
magnetic cell sorting using CD14 Microbeads (Miltenyi Biotec).
Monocytes (>95% CD14+ cells) were cultured at 0.56106 cells/ml for
three days in RPMI medium supplemented with 10% FCS (complete
medium) at 37 C˚ under a humidified atmosphere with 5% CO2. Resident
LPMs were isolated from mice as described below and then were incubated
in complete medium for 2 h at 37 C˚ under 5% CO2. Then, the medium was
removed and plates were washed with PBS to eliminate cells in suspension
and enrich for adherent cells. After adherence, the typical change in
morphology was observed in human and mouse macrophages. To induce
oxidative stress, H2O2 at 150 mM was added for 1 h, then the cells were
washed twice with PBS and cultured for an additional 12 h in normal fresh
medium. Cellular senescence was monitored by senescence-associated b-
galactosidase activity (SA-b-Gal), as previously described (Haendeler
et al., 2004; Blanco et al., 2008; Cassado Ados et al., 2011).
Macrophage differentiation and polarization of U937 cells
Stable U937 transfectants were cultured at 26105 cells/ml for three days in
complete RPMI with or without 50 nM phorbol-12-myristate-
13-acetate (PMA). Upon treatment with PMA, cells underwent growth
arrest and a change of morphology owing to their attachment to the
substrate. The differentiation to macrophages was confirmed using
immunofluorescence flow cytometry by measuring the increased surface
expression of CD11b (Bear-1 antibody; ab36939, Abcam). For polarization
studies, U937 stable transfectants were differentiated to macrophages with
PMA as above, but adding 25 mg/ml of LPS for the last 12 h of PMA
treatment. The amount of the cytokines present in the supernatant after the
LPS/PMA treatment was analysed with the Human Cytokine Array panel A
(R&D Systems), according to the manufacturer’s instructions.
Animals
Specified pathogen-free C57Bl/6J male 8–48-week-old mice were used in
the experiments. All animal procedures were in accordance with the
guidelines for animal use published by Conseil de l’Europe (No. L358/1-
358/6, 1986), Spanish Government (BOE No. 67, pp. 8509–8512, 1988, and
BOE No. 256, pp. 31349–31362, 1990) and were approved by the National
Research Council of Spain (CSIC) Animal Care and Use Committee. In
order to recruit SPMs, mice were intraperitoneally injected with 1 mg of
Zymosan A from Saccharomyces cerevisiae (Z4250, Sigma-Aldrich) in
0.5 ml of sterile PBS. For the isolation of peritoneal cavity cells (both
recruited SPMs and tissue-resident LPMs) all animals were deeply
anaesthetized with isofluorane and killed by cervical dislocation. After
injecting 10 ml of sterile PBS into the peritoneal cavity, a massage was
performed for a few seconds and ,8–9 ml of the injected liquid was
recovered. Then, always under sterile conditions, the cell suspension was
transferred to a 15-ml tube and centrifuged at 250 g for 6 min. The pellet
was resuspended in 1 ml DMEM with 10% FCS, and the cell suspension
was divided in wells of a P-6 plate and brought to a final volume of 2.5 ml of
DMEM with 10% FCS. Cells were incubated for 2 h at 37 C˚ under 5% CO2.
After this time, the medium was removed and washed with 3 ml of PBS to
remove the suspended cells and enrich the sample with adherent cells
(macrophages from the peritoneal cavity). The cells were maintained in
culture in DMEM with 10% FCS and the medium was changed every 24 h.
Quantitative real-time RT-PCR
Total RNA was isolated from cells using the SpeedTools total RNA
extraction kit (Biotools) and reverse-transcribed using iScript cDNA
Synthesis kit (BioRad). The cDNA was amplified in triplicates using
specific oligonucleotides. For experiments with U937 cells, oligonucleotides
for selected genes were designed according to the Universal Probe Library
System (Roche Diagnostics) for quantitative real-time PCR (qRT-PCR). For
the U937 polarization and phenotype screening, the levels of typical M1 or
M2 genes were normalized to those of the TBP (TATA box binding
protein), HPRT1 (hypoxanthine phosphoribosyltransferase 1) and RPLPO
(large ribosomal protein) housekeeping genes. For experiments with
human and mouse macrophages, the cDNA was used as a template for real-
time PCR performed with specific primers. Mouse primers were: Pai1
(FW, 59-GTCTTTCCGACCAAGAGCAG-39; RV, 59-GACAAAGGCT-
GTGGAGGAAG-39); S-endoglin and L-endoglin (FW, 59-GACCTGTCT-
GGTAAAGGCCTTGTCCTG-39); L-endoglin (RV, 59-CTGGGGCCAC-
GTGTGTGAGAATAG-39); S-endoglin (RV, 59-CTGAGGGGCGTGGG-
TGAAGG-39). Human primers were: PAI1 (FW, 59-CAGACCAAGAGC-
CTCTCCAC-39; RV, 59-ATCACTTGGCCCATGAAAAG-39); L-endoglin
and S-endoglin (FW, 59-ACCTGTCTGGTTGCACAAGCAAAGG-39); L-
endoglin (RV, GGGAACCGCGTGTGCGAGTAG-39); S-endoglin (RV-
59-GGGAACCTGGGAGCGGGG-39). Primers for human and mouse 18S
rRNA were: FW, 59-CTCAACACGGGAAACCTCAC-39; and RV, 59-
CGCTCCACCAACTAAGAACG-39. Samples were amplified using the iQ
SyBR-Green Supermix (BioRad). Amplicons were detected using an iQ5
real-time detection system (BioRad). Transcript levels were normalized to
18S levels.
Statistical analysis
All the experiments were performed at least three times. Statistical
analyses were performed on GraphPad Prism 5 for Windows (La Jolla,
CA). All the statistical data are presented as mean6s.d. Statistical
significance was calculated using an unpaired, two-tailed Student’s t test
or, when appropriate, by ANOVA followed by Bonferroni’s post hoc
testing. A value of P,0.05 was considered significant.
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SUPPLEMENTARY FIGURE LEGENDS 
 
Supplementary Figure 1. SILAC labelling and analysis strategy in endoglin 
monocytic transfectants. U937 transfectants were harvested and labelled with light 
(Lys, Arg; C12), medium (Lys, Arg; C13) and heavy (Lys, Arg; C13-N15) amino acids 
by culturing in SILAC media. Equal number of cells, in different combinations, were 
mixed, lysed and fractionated for individual membrane, cytoplasm and nuclear analysis 
using SDS-PAGE followed by trypsin digestion. Then, protein identification and 
quantitation was carried out by liquid chromatography and mass spectroscopy (LC-MS) 
(A). Light, medium and heavy spectra of the peptides was obtained in an LTQ Orbitrap 
equipment and analysed to get the protein level ratios based on the detected relative 
abundance (B). Labelling efficiency was checked and ratios where manually normalized 
in all subcellular fractions to correct the mixing-labelling variability (C).  
 
Supplementary Figure 2. Ingenuity pathway analysis of SILAC proteome list. The 
bio-informatic Ingenuity Pathways Analysis (IPA) of the final protein list obtained after 
SILAC analysis is shown. The Ingenuity Knowledge Base (Genes Only) was used as a 
reference set. Direct and indirect relationships for human genes with high confidence in 
experimentally observed interactions were analyzed. Predicted networks (with high 
confidence) were also checked. Top 25 significantly altered biofunctions are shown for 
L-endoglin (A) and S-endoglin (B) U937 transfectants respect to mock controls. 
*Illustrative common biofunctions affected in both transfectants; #Example of specific 
biofunction affected in L-endoglin transfectants. The list of biofunctions is ordered from 
top to bottom according to their statistical significance (between p<1.19x10-9 and 
p<2.98x10-2). The area in the pie diagram relates to the number of altered proteins in 
each biofunction. 
 
Supplementary Figure 3. Quantitative analysis of protein expression in endoglin 
U937 transfectants. Logarithmic ratio distribution of the SILAC raw data after 
normalization respect to mock transfectants. Most of the identified proteins for both 
transfectants (>4,000) have a value close to zero. Broken arrows indicate the 
approximate cut-off values (0.585 and -0.322).  
Journal of Cell Science | Supplementary Material
Supplementary Table 2. SILAC ratios of the top ten most deregulated 
proteins in L-endoglin and S-endoglin transfectants. 
 
Logarithmic SILAC ratios are shown. Asterisks indicate proteins down- or up-regulated in both 
endoglin transfectants. Please note that not all the marked proteins of a given transfectant are 
shared in the top ten list of the other one (See Supplementary Figure 1). ANXA2, Annexin A2; 
APPL1, DCC-interacting protein 13-alpha; ARRB1, Beta-arrestin-1; BRD3, Bromodomain-
containing protein 3; C11orf31, Uncharacterized protein C11orf73; CC2D1A, Coiled-coil and C2 
domain-containing protein 1A; CDA, Cytidine deaminase; COPS5, COP9 signalosome complex 
subunit 5; CST7, Cystatin-F; CSTG, Cathepsin G; CTR9, RNA polymerase-associated protein 
CTR9 homolog; DAK, Bifunctional ATP-dependent dihydroxyacetone kinase/FAD-AMP lyase 
(cyclizing); DCTPP1, dCTP pyrophosphatase 1; DHPS, Deoxyhypusine synthase; FBXO4, F-box 
only protein 4; GGCT, Gamma-glutamylcyclotransferase; IL4I1, L-amino-acid oxidase; IQGAP3, 
Ras GTPase-activating-like protein IQGAP3; LIG1, DNA ligase 1; LRPAP, Alpha-2-macroglobulin 
receptor-associated protein; MARS2, Methionyl-tRNA synthetase mitochondrial; NR2F, COUP 
transcription factor 2; NR2F2, COUP transcription factor 2; PRTN3, Myeloblastin; PSTPIP1, 
Proline-serine-threonine phosphatase-interacting protein 1; PSTPIP2, Proline-serine-threonine 
phosphatase-interacting protein 2; RAB27B, Ras-related protein Rab-27B; RPL15, 60S 
ribosomal protein L15; S100A11, Protein S100-A11; SRP19, Signal recognition particle 19; 
SRP54, Signal recognition particle 54 kDa protein; TES, Testin; TRIM27, Zinc finger protein RFP; 
UBASH, Ubiquitin-associated and SH3 domain-containing protein B; UBASH3B, Ubiquitin-
associated and SH3 domain-containing protein B; VIM, Vimentin. 
Proteins 
MARS2 
ARRB1 
CTSG* 
PSTPIP2* 
DAK 
IL4I1 
SRP54 
NR2F2 
CST7* 
PSTPIP1 
Proteins Ratio
LRPAP1* -1.260
TES -1.248
UBASH3B -1.239
APPL1 -1.229
VIM* -1.220
LIG1* -1.220
DHPS -1.209
FBXO4 -1.208
RPL15 -1.202
DCTPP1* -1.143
Proteins Ratio
CTSG* 2.817
PRTN3* 2.687
PSTPIP2* 2.435
SRP19 2.293
TRIM27 2.026
CDA 1.980
NR2F2 1.633
COPS5 1.419
C11orf31 1.410
CST7* 1.381
Proteins Ratio
ANXA2* - 1.810
UBASH3B - 1.678
GGCT - 1.556
RAB27B - 1.393
CC2D1A - 1.335
CTR9 - 1.292
S100A11 - 1.266
IQGAP3 - 1.262
LIG1* - 1.239
BRD3 -1.218
L- Endoglin 
UP DOWN
S-Endoglin 
UP DOWN
Ratio
2.875
2.853
2.808
2.133
1.974
1.887
1.827
1.762
1.711
1.680
Supplementary Table 1. List of differentially expressed proteins obtained from
SILAC analysis.
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